Microba Life Sciences (ASX:MAP) Other Stockholders Equity: A$-0.00 Mil (As of Dec. 2025)


What is Microba Life Sciences Other Stockholders Equity?

Microba Life Sciences ASX:MAP -2.50% Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Microba Life Sciences's Other Stockholders Equity for the quarter that ended in Dec. 2025 was A$-0.00 Mil.

Microba Life Sciences's quarterly Other Stockholders Equity increased from Dec. 2024 (A$-0.00 Mil) to Jun. 2025 (A$-0.00 Mil) but then stayed the same from Jun. 2025 (A$-0.00 Mil) to Dec. 2025 (A$-0.00 Mil).

Microba Life Sciences's annual Other Stockholders Equity declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$-0.00 Mil) but then increased from Jun. 2024 (A$-0.00 Mil) to Jun. 2025 (A$-0.00 Mil).

Microba Life Sciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Other Stockholders Equity Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
-0.00 0.00 -0.00 -0.00

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00

Microba Life Sciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of A$-0.00 Mil mean?
Microba Life Sciences (ASX:MAP) has a Other Stockholders Equity of A$-0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Microba Life Sciences and its competitors.
Is Microba Life Sciences' Other Stockholders Equity too high?
Microba Life Sciences' current Other Stockholders Equity is A$-0.00 Mil.
How does Microba Life Sciences' Other Stockholders Equity compare to TMO and DHR?
Microba Life Sciences' Other Stockholders Equity of A$-0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Microba Life Sciences and its competitors. Microba Life Sciences's current Other Stockholders Equity is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84.4% below its estimated fair value. The current Other Stockholders Equity is A$-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.